Progressive familial intrahepatic cholestasis: Genetic basis and treatment

Clinics in Liver Disease

Volumn 4, Issue 4, 2000, Pages 753-763

  Jacquemin, Emmanuel ^b  

^a BICÊTRE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

URSODEOXYCHOLIC ACID;

CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FAMILIAL DISEASE; HUMAN; INTRAHEPATIC CHOLESTASIS; PATHOGENESIS; REVIEW; SURGICAL APPROACH;

EID: 0033767714     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70139-2     Document Type: Article

References (50)

1. Progressive familial intrahepatic cholestasis (PFIC): Evidence for genetic heterogeneity by exclusion of linkage to chromosome 18q21-22
2. Intrahepatic cholestasis: Order out of chaos
3. ++, mechanisms defective in cholestasis
4. Byler-like familial cholestasis in an extended kindred
5. Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): Evidence for heterogeneity
6. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis
7. Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21-q22, the benign recurrent intrahepatic cholestasis region
8. Byler disease: Fatal familial intrahepatic cholestasis in an Amish kindred
9. Byler disease: Fatal familial intrahepatic cholestasis in an Amish kindred
10. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis
11. Rapid correction of mdr2 deficiency by transplantation of MDR3 transgenic hepatocytes
12. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis
13. Selective surgical management of progressive familial intrahepatic cholestasis (Byler's disease)
14. Histologic pathology of the liver in progressive familial intrahepatic cholestasis
15. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver
16. Genome screening by searching for shared fragments: Mapping of a gene for benign recurrent intrahepatic cholestasis
17. Ursodeoxycholic acid improves ethinyl estradiol induced-cholestasis in the rat
18. Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis (Byler disease)
19. 27-steroid dehydrogenase/isomerase deficiency
20. Ursodeoxycholic therapy in pediatric patients with progressive familial intrahepatic cholestasis
21. MDR3 deficiency: Progressive familial intrahepatic cholestasis (PFIC) due to MDR3 gene mutations
22. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy
23. Genetic basis of progressive familial intrahepatic cholestasis
24. Progressive familial intrahepatic cholestasis
25. The canalicular bile salt exporting protein BSEP is not expressed in patients with progressive familial intrahepatic cholestasis type 2
26. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis
27. Byler's disease: Fatal intrahepatic cholestasis
28. Structure of the human MDR3 gene and physical mapping of the human MDR locus
29. Normal serum gamma-glutamyl-transpeptidase activity identifies groups of infants with idiopathic cholestasis with poor prognosis
30. Diagnostic value of serum γ-glutamyl transpeptidase activity in liver diseases in children
31. Cloning and tissue distribution of the rat homologue of the human gene involved in familial intrahepatic cholestasis type 1
32. Progressive intrahepatic cholestasis among the Arab population of Israel
33. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy
34. Serum bile acids in primary biliary cirrhosis: Effect of ursodeoxycholic acid therapy
35. Phosphatidylcholine translocase: A physiological role for the mdr2 gene
36. 4-3 oxosteroid 5β-reductase deficiency described in identical wins with neonatal hepatitis. A new inborn error in bile acid synthesis
37. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
38. Tissue distribution of the human MDR3 P-glycoprotein
39. The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice
40. Hepatocyte-specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidycholine excretion absent in mdr2 (-/-) mice
41. Orthotopic liver transplantation for Byler disease
42. Identification of a locus for progressive familial intrahepatic cholestasis (PFIC2) on chromosome 2q24
43. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis
44. Bile acids profiles in siblings with progressive intrahepatic cholestasis: Absence of biliary chenodeoxycholate
45. Molecular pathogenesis of cholestasis
46. Effects of ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 p-glycoprotein gene
47. Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis
48. Clinical and biochemical findings in progressive familial intrahepatic cholestasis
49. Progressive familial cholestatic cirrhosis and bile acid metabolism
50. Progressive idiopathic cholestasis presenting with profuse watery diarrhea and recurrent infections (Byler's disease)